Exhibit 99.1
The Chemours Company
Schedule II - Valuation and Qualifying Accounts
Year Ended December 31, | ||||||||||||
(Dollars in millions) | 2015 | 2014 | 2013 | |||||||||
Accounts Receivable - Allowance for Doubtful Accounts | ||||||||||||
Balance at beginning of period | $ | 4 | $ | 7 | $ | 6 | ||||||
Additions charged to expenses | 1 | 1 | 2 | |||||||||
Deductions from reserves1 | — | (4 | ) | (1 | ) | |||||||
Currency translation | (1 | ) | — | — | ||||||||
Balance at end of period | $ | 4 | $ | 4 | $ | 7 | ||||||
Deferred Tax Assets - Valuation Allowance | ||||||||||||
Balance at beginning of period | $ | 36 | $ | 26 | $ | 19 | ||||||
Net charges to income tax expense | — | 10 | 7 | |||||||||
Release of valuation allowance2 | (36 | ) | — | — | ||||||||
Balance at end of period | $ | — | $ | 36 | $ | 26 |
1 | Bad debt write-offs were less than $1 for the year ended December 31, 2015. |
2 | Release of valuation allowance during 2015 was primarily related to the tax attributes retained by DuPont pursuant to the tax matters agreement. |